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The Australian government’s General Practitioner (GP) 
super clinics programme aims to provide well-integrated, 
multidisciplinary, patient-centred care for people with 
chronic disease. However, there is no research into the 
current role of pharmacists in this setting. 
 
Aims 
To explore the perspectives of GP super clinic staff on 
current and potential (future) pharmacist-led services 
provided in this setting. 
 
Methods  
Individual interviews (facilitated using a semi-structured 
interview guide and thematically analysed) were conducted 
with purposively sampled staff of a GP super clinic in a semi-
rural location in the state of New South Wales, until theme 
saturation. Participating staff included (n=9): three GPs, one 
pharmacist, one nurse, one business manager, and three 
reception staff. 
Results  
Three themes emerged conveying perspectives on: working 
relationships between staff; a pharmacist’s current role; and 
potential future roles for a pharmacist. All clinic staff 
actively engaged the pharmacist in their “team approach”. 
Currently established roles for home medicines reviews 
(HMRs) and drug information were well supported, but 
needed to be expanded, for example, with formalised case 
conferences between GPs, pharmacists, and other staff. 
New roles needed be explored in auditing medication use, 
optimising medication records, specialised drug 
information, dispensing, and prescribing. Although GPs had 
differing views about opportunities for pharmacists’ 
prescribing in this setting, they saw several benefits to this 
service, such as reducing the time pressure on GPs to 
enable more effective consultations. 
 
Conclusion 
Results suggest a pharmacist’s services can potentially be 
better used within the multidisciplinary super clinic model 
of care to address current gaps within the semi-rural 
practice setting. Any future role for the pharmacist could be 
addressed as part of a formalised, strategic approach to 
creating an integrated healthcare team, with attention to 
funding and government legislation. 
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What this study adds:  
1. What is known about this subject?  
Pharmacist-led interventions can improve medicines use, 
although the integration of pharmacists into 
multidisciplinary teams has traditionally been limited to 







2.  What new information is offered in this study? 
A pharmacist’s expertise (medication review, drug 
information) is highly valued in a GP super clinic (primary 
care) setting, with support for expanded roles in monitoring 
(medicines use, prescribing), medication profiling, and 
prescribing.  
 
3. What are the implications for research, policy, or 
practice?  
There is a critical need to develop strategies, incorporating 
appropriate remuneration and funding, to further explore 
and support the integration of pharmacists and expansion 
of their services into multidisciplinary primary care clinics.   
  
Background 
Chronic diseases are associated with high healthcare use 
and costs in the community.  The Australian government’s 
GP super clinic programme is designed to provide well-
integrated, multidisciplinary patient-centred care, via a 
range of health services in a single location, focusing 
particularly on the needs of people with chronic disease.1  
 
Pharmacists are experts in medications. They can support 
the role of the general practitioner (GP) in primary care to 
optimise medicine use and management. Targeted 
interventions (e.g., medication review) by pharmacists can 
improve medicines use,2 appropriateness of prescribing,3 
and the prescribing of evidence-based therapies.4 
Pharmacist-led interventions can also successfully optimise 
therapies that require complex risk versus benefit 
assessments.5 Furthermore, comprehensive pharmacy 
disease management services (e.g., for asthma), which use a 
patient-centred approach, can improve self-management 
and adherence to therapy, as well as clinical outcomes.6–7 
Given that pharmacotherapy is the first-line healthcare 
intervention used in primary care, GP super clinics present 
an opportunity for GPs and pharmacists to work 
collaboratively in co-located health services to optimise 
medicines use by patients.  
 
GP super clinics are a fairly recent innovation in Australian 
primary health care, comprising one part of the 
government’s 2007 suite of reforms across the health 
sector.8 As such, any pharmacist service within a super clinic 
would have to follow a new and innovative practice model. 
Pharmacists have been integrated into primary care clinics 
overseas with success.9–13 A recent Australian study has 
explored the experiences of stakeholders during the 
integration of pharmacists in primary care settings.13 In 
Australia, integrating a pharmacist into a general practice 
setting can improve the timeliness and completion rates of 
home medicines reviews (HMRs).  
 
There has been much discussion around the potential role 
of pharmacists in GP super clinics in Australia14–17 and 
integrated primary healthcare teams.16–18 However, there is 
no research into the current role of a pharmacist in an 
Australian GP super clinic. This study explored the 
perspectives of healthcare practitioners and clinic staff 
about the current pharmacist services, and potential future 
roles, in a GP super clinic setting.  
 
Method 
A qualitative study comprising individual face-to-face 
interviews was conducted. The interviews were facilitated 
by two experienced researchers using a semi-structured 
interview guide, which was developed using an exploratory 
case study approach.19 The interviews were recorded and 
transcribed verbatim by an independent third party (a 
transcription company) and participants were de-identified. 
The transcripts were thematically analysed using manual 
inductive coding to elicit key emergent themes; interviews 
were conducted to ensure theme saturation. Approval was 
granted from the institutional Human Research Ethics 
Committee. 
 
The sampling frame for this study comprised all 19 staff of a 
GP super clinic, including the clinic administrators (i.e., 
receptionists), who were regarded to be the central and 
initial contact points for all patients and staff in coordinating 
referrals and appointments (Figure 1). Using purposive 
sampling, clinic staff were invited to participate in an 
interview to canvas a range of perspectives (Figure 1).  
 
The clinic is one arm of a GP super clinic located within a 
semi-rural location in New South Wales, Australia, 
representing an area of lower cost housing; the major 
patient demographics of the clinic are elderly patients and 
families with lower-earning capacity/pensions. The clinic 
operates on a “hub and spoke” model for GP super clinics, 
where a closely located clinic is the “hub” and other 
“spokes” are within the area (within 50km). Within this 
clinic, the pharmacist is available on-site (for consultation) 
once every fortnight (for one day from 9am to 5pm). 
 
Results 
Nine staff members of the clinic participated in individual 
interviews, each of around 20 minutes in length. These 
included GP (1), pharmacist (1), registered nurse (1), 
administrator (business manager) (1), and reception staff 





the nature of working relationships between clinic staff; 
current role of the pharmacist in the clinic; and potential 
future roles for a pharmacist in the clinic.  
 
Nature of working relationships between clinic staff  
The clinic purposefully refers patients to other allied health 
professionals in the area, and its staff believe they have 
good, open lines of communication with these colleagues 
(Table 1). Within the clinic, a major strategy for maintaining 
communication between all staff is the weekly staff 
meeting. The part-time nature of some healthcare 
professionals (HCPs), the dynamics of the daily practice, and 
the lack of a designated meeting room, means that the staff 
meetings are rarely attended by all staff and consequently 
focus on administrative issues. However, the possibility of 
having the pharmacist attend the regular staff meetings and 
using them as a forum for case conferences and information 
exchange was emphasised. 
 
Participants spoke about very positive working relationships 
they have developed: “Quite close-knit” (2), “good 
communication between the pharmacists and the GPs” (2), 
and “excellent interaction” (1) were some positive 
comments relating to staff relationships. Further, respect 
for the observations and feedback from non-HCP staff as 
being of value to the “team approach” to health care at the 
clinic was outlined. Reference to the reception staff as being 
the “eyes and ears” (7) of the clinic was an example.  
 
Current role of the pharmacist in the clinic 
Within this clinic, the pharmacist’s role focuses on home 
medicines reviews, including patient education and 
counselling, and providing drug information to staff, albeit 
constrained by having only one day per fortnight allocated 
for these services.  
 
Home Medicines Reviews 
Participants spoke of the value of having the pharmacist 
currently involved in the HMRs (Tables 2 and 3), including 
provision of patient education and counselling, improved 
health outcomes for patients through medication changes, 
communication with the GP, periodic re-evaluation of 
patients’ medications, and access to the pharmacist’s 
knowledge of medications.  
 
Staff had varying perceptions about patients’ level of 
acceptance of HMRs because not all patients necessarily 
agreed to having one (Table 4). Staff suggested that some 
patients appear to be resistant to change and/or have 
“uneasy” perceptions about the intentions of an HMR. For 
those patients who happily participated with the pharmacist 
in the HMR process and were able to positively embrace 
changes in their management plans, significant 
improvements to health outcomes have been observed. 
 
In trying to deliver optimal HMR, the pharmacist was 
impeded by the generally “one-off” nature of the service, 
and was therefore not always fully aware of the patient’s 
medical history.  
 
“The difficulty with the medication review by a 
pharmacist is they’re not familiar with the clinical picture 
of the patient … they've only seen them once.” (9)  
 
Many staff, particularly GPs, suggested that this challenge 
could be overcome by having patients access the 
pharmacist’s services more than once per fortnight and for 
more than one visit as part of the HMR. 
 
“[the pharmacist, has] got to be here more, see the 
patients more, or maybe see a patient a few times, and 
then say, ‘Look, I’ll do the review’. Because at the 
moment, I think they basically see the patient once, look 
at their medication, and make a determination.” (9) 
 
Information provision  
A current role of the pharmacist was to respond to the clinic 
staff requests for drug information (Table 5). GPs are 
targeted by drug company representatives and having the 
pharmacist available to discuss new drugs was 
advantageous, and the existing relationship among clinic 
staff allowed for successful information exchange.  
 
Potential future roles for a pharmacist in the clinic  
All participants felt a pharmacist could expand his/her role 
within a clinic environment (Table 6) to include: monitoring 
patients’ use of and GPs’ prescribing of medications; 
optimising medications records; further accessing the 
pharmacist’s drug knowledge; having a dispensary on-site; 
and possibly pharmacist prescribing. 
 
Monitoring medication use and GP prescribing 
Participants universally supported the possibility of the 
pharmacist taking on an expanded role in monitoring 
patients’ use of medications, stating that collecting this 
information would be very useful. One staff member related 
an example from a Brisbane clinic (QLD) where additional 
GPs were employed in a monitoring capacity.  
 
“They reviewed each patient on a daily or weekly or 
monthly basis, and reported back to the GP. GPs would 





they did the monitoring. Someone else did the 
monitoring, so it doesn’t have to be [the regular GP].” (9) 
 
When asked if the pharmacist could undertake this 
monitoring role, the interviewee suggested:  
 
“It wouldn’t matter who did it. It was just a matter of 
knowing what you’re doing, and doing it… it was very 
good. You knew that the patients’ levels were monitored 
and managed.” (9) 
 
In addition to monitoring patients’ use of medicines, it was 
suggested that a pharmacist could also monitor GPs’ 
prescribing patterns within a clinic to assist with self-
reflection and achieving best practice. 
 
Optimising medication records 
Expanding the pharmacist’s role into optimising medication 
records (patient files) was suggested, providing GPs and 
nurses with up-to-date information on patients’ regimens. 
The opportunity for the pharmacist to undertake this role 
presents itself when he/she accesses the electronic patient 
files to complete the HMR reports.  
 
Further access to knowledge 
Participants indicated that drawing further on the 
pharmacist’s specific knowledge of medications would be 
possible and a useful and important role to pursue, 
including educating the general public. 
 
Dispensing 
Having a full-time pharmacist working within a dispensary 
on-site was suggested as a very valuable asset to the clinic. 
However, current legislation governing the proximity of 
pharmacies could impact on this for many clinics.20  
 
Prescribing 
A particular issue for clinic staff was efficiently handling the 
needs of patients requiring prescriptions for continuing 
medication, but who had lost prescriptions, run out of 
medication, and had no further repeats. Reception staff and 
GPs were concerned by the amount of time spent on 
patients requiring re-issue of prescriptions. However, 
opinions differed as to whether the pharmacist could take a 
lead role in re-issuing prescriptions. One participant 
reiterated the pharmacist’s time constraints and the need 
for patients to be more familiar with the pharmacist if this 
role could be explored further:  
 
 “She is only here once a fortnight at the moment…. 
she'd get extremely busy, with doing her reviews as well 
as handling that sort of stuff… more it's sort of getting 
the doctor to say okay, you need to come and see me…  
It would only take for them to get familiar with [the 
pharmacist] before they'd be comfortable to see her.” (3) 
 
While participants indicated that many patients would 
rather not see the GP to pick up their new prescriptions, 
they also felt that there was a need for clinical review with 
the GP, as the decisions relating to medication have to be 
firmly situated within the patient’s full medical history, 
which the pharmacist may not be privy to. 
 
One participant was strongly in favour of pharmacists 
assisting with prescribing (based on previous experience 
with pharmacist prescribers in the UK), and the benefits of 
pharmacist prescribing were also recognised by other clinic 
staff. One staff member spoke positively of having the 
pharmacist take a lead role in prescribing, but indicated the 
pharmacist, nurse, and GP should liaise about the 
management of the patient. Several participants felt there 
were issues confounding a role for pharmacists’ in 
prescribing, changing, or adjusting medication, and saw the 
constraints of time and legislation as being prohibitive.  
 
Constraints on potential future roles 
Some notable constraints continually arose regarding 
opportunities for the pharmacist to further contribute to 
the clinic’s service provision (Table 7): the time the 
pharmacist was physically on-site; funding constraints, 
whereby only HMRs had financial support from the 
government; and government legislation relating to 
pharmacists and prescribing issues.  
 
There was consensus that the clinic’s patients would benefit 
from having the pharmacist work full-time or an additional 
day per week, but this was limited by funding availability. 
The government’s funding framework (Medicare) for 
services provided by pharmacists was discussed as being 
limited to HMRs, and the practicalities of this funding 
framework limited their vision for increased pharmacy 
services within the clinic. It was also suggested that it would 
be helpful for the pharmacist to be paid for following up 
after HMRs, rather than currently providing the service for 
free. 
 
The legal constraints around pharmacists prescribing were 
also discussed. Although pharmacists in other countries (the 
United Kingdom, Canada, the United States)21–24 have 
government approval for some prescribing roles, this is not 
currently the case in Australia. However, one participant 





this regard, referring to the “medication 
continuance”/“continued dispensing” initiative, wherein 
pharmacists can supply a standard pack of a HMG-CoA 
reductase inhibitor (“statin” for high cholesterol) or oral 
contraceptives under certain specific conditions:30 
 
“They’re negotiating with the government to do repeat 




Our study has found that within a GP super clinic in a semi-
rural setting a pharmacist can provide, and be supported in, 
home medicines reviews and drug information. Practically 
all participants were keen to expand this service, suggesting 
that increasing the pharmacist’s presence at the clinic 
would improve contact with patients. There were varying 
levels of support for expanding the pharmacist’s role into 
the areas of monitoring (GP prescribing, patients’ 
medication use), optimising patient records, providing drug 
information, dispensing, and prescribing, although time and 
money were key constraints.  
 
The current role of the pharmacist within the clinic, one of 
provision of HMRs and drug information, was well 
supported, consistent with Freeman et al.’s exploratory 
work,16 which described a similar role for pharmacists in the 
general practice setting. It has been found that HMR 
recommendations are more likely to be implemented when 
a pharmacist is integrated into a practice.25 The usefulness 
of HMRs in this clinic setting in terms of patient education, 
communication with GPs, and review of medication 
regimens are supported.26 
 
Ways to enhance ongoing communication between GPs and 
pharmacists were suggested, including regular formalised 
case conferences, and extending the HMR process beyond 
the current “one-off” service. More fully integrating the 
pharmacist into a clinic27 would enable him/her to see 
patients on an ongoing basis to improve communication on 
all levels and patient outcomes. 
 
Various potential new roles for the pharmacist were 
discussed, the expansion of which would help cement a 
base of trust and respect between pharmacists and their 
colleagues to facilitate more innovative roles. Auditing of 
prescribing and medication use was viewed by GPs as 
potentially useful, as described elsewhere,16,18 which is 
already established in hospitals and some clinics. Possible 
expansion into pharmacist prescribing received more mixed 
responses as, although participants could see the utility of 
this, a range of concerns were expressed, including a need 
for GP review, overlapping roles with the GP, pharmacists’ 
limited knowledge of the patient’s history, and legislation. 
Pharmacist prescribing remains a contentious issue within 
the Australian healthcare environment. It is perceived both 
positively and negatively by pharmacists, patients, and 
practice managers, but only negatively by GPs.16 GPs’ 
expectations of pharmacists’ roles, and views on possible 
expansion of their roles, have not always been 
encouraging.16,28 
 
GP-pharmacist collaboration within a clinic setting is 
challenging12 and highly dependent upon the experiences 
and perceptions of the individuals involved. Factors 
previously identified as critical in increasing GPs’ acceptance 
of a pharmacist’s integration into a primary care team 
include adaptability and practical demonstration of 
potential use and benefit.12,29 Indeed, one of the GPs in this 
study was very supportive of pharmacist prescribing based 
on previous positive experiences with this service overseas, 
whereas other GPs were more hesitant. GPs recognise the 
benefits of pharmacist services through exposure over 
time,10 and acknowledging this may assist in establishing 
trust and acceptance of new roles. In our study, staff also 
recognised the importance of regular meetings to furthering 
a team approach to patient care within the clinic. The 
adoption of a formalised, deliberate, and strategic approach 
within these meetings towards establishment and 
evaluation of an integrated healthcare team12,30,31 would 
assist in establishing shared expectations of the 
pharmacist’s role and capabilities.  
 
Funding is needed for the pharmacist to expand his/her role 
within the clinic and provide additional services. A lack of 
remuneration for pharmacist services above and beyond 
dispensing and HMRs was reported in our study, as has 
been previously identified in the expansion of a 
pharmacist’s role.12,13,28 Currently, the clinic pharmacist is 
only funded for a single HMR, while follow-up visits (as 
many as six) are conducted by the pharmacist without 
remuneration, as are other services, including providing 
drug information (involving research and the printing of 
information), and attending case conferences. In addition, 
HMR funding has recently been capped at only 20 HMRs per 
pharmacist per month.32 Proposing a funding model which 
includes remuneration to pharmacists for these services 
acknowledges their value and importance in improving 
patients’ quality of life of, and would enable pharmacists to 







• Government remuneration for pharmaceutical 
services,13,16 although this funding is finite. 
• Having pharmacists as salaried employees within a 
clinic, akin to practice nurses.13 
• Division of roles so that the pharmacist facilitates the 
patient consultation for the GP, and thus make visits 
to the GP more efficient, allowing greater capacity to 
generate revenue for the clinic through streamlined 
patient consultations.  
 
Conclusion 
A pharmacist’s services can potentially be better used 
within the multidisciplinary super clinic model of care to 
address current gaps within the semi-rural practice setting 
and/or issues in medicines management. Currently, 
established roles in home medicines reviews and drug 
information are well supported within this environment, 
and need to be expanded, e.g., with formalised case 
conferences. New roles should be explored in auditing 
medication use, optimising medication records, specialised 
drug information, dispensing, and prescribing. Any future 
role for the pharmacist could be addressed as part of a 
formalised, strategic approach to creating an integrated 
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Reference for Map: http://www.bluemts.com.au/info/about/maps/ 
The GP super clinic 
 Operates on a “hub and spoke” model for GP super clinics (a closely 
located clinic is the “hub”)  
 Semi-rural location—area of lower-cost housing 
 Patient demographics: elderly patients, families with lower-earning 
capacity (e.g., government pensions)  
Services provided by the GP super clinic 
 Staff: General practitioners (6), registered nurses, clinical 
pharmacist (1), osteopath (1), dietician (1), psychotherapist (1), 
massage therapist (1), exercise physiologist (1), chiropractor (1), 
podiatrist (1) 
 Clinic also includes an administrator (business consultant), 
reception/administrative staff 
 Comprehensive range of health services, as well as hearing services, 
sleep services, pathology 
 NB/access to each medical and allied health professional/ service is 
not on a full-time basis 
Study Participants 
 n=9 (mean interview length = 20 minutes) 
 n=3 General practitioners 
 n=1 Pharmacist  
 n=1 Registered nurse  
 n=1 Administrator (Business Manager) 
 n=3 Reception staff 
 
Table 1: Nature of working relationships between clinic staff 
Aspect Quote(s) 
Relationship with 
other allied health 
professionals in the 
area 
“We just have an alliance, almost, with them [Allied Health]. But there is good communication with the 
different health professionals, where a doctor might refer to their exercise physiologist, say, and a letter 
will come back saying, … ‘This is what we’ve identified. This is the treatment plan we’ve opted for.’“ (2) 
Clinic meeting “Within that clinical meeting, periodically, we should have the pharmacist and the dietician. It doesn’t 
always have to be both, or the nurse… I'd like to see the pharmacist get involved in those. When new 
drugs come along, we’d go to a meeting we should sit and talk and the pharmacist should put information 
about the data and about side effects and costs.” (8)  
Role of reception 
staff 
“[operating] as a team approach because if our nurse sees something or another GP sees something we 












generally by the GP, 
but also by the nurses. 
“…so we recognise that a patient's on a complex medication regime, then they… quite possibly could 
benefit from the home medicines review to try and, you know, minimise medication, if possible, and just to 
ensure that what they're on is appropriate.” (6) 
 
“What normally happens is that the patient would come in, or the doctor might think of a patient who 
they haven’t seen for awhile who’s eligible. So they would have a consultation with the GP. The GP would 
make the referral. They would then have an appointment with [the pharmacist]… followed by an 
appointment with the GP” (2) 
 
“I identify patients that are eligible for home medicines or would benefit mainly from a home medicines 
review through some of the health assessments that we do here.” (Nurse) 
Reception staff 
contact the patient 
and arrange an 
appointment time. 
“We book an appointment with [the pharmacist] and then we follow that with an appointment with a 
GP.” (2) 
 
“When we make the appointment…[the pharmacist] can come to you if you like.” (3) 
The pharmacist 
conducts the HMR at 
the patient’s home. 
“She will … go and visit the patient at home … obviously with a referral from the GP. She sits down with 
them, and talks about everything that they’re taking.” (2) 
 
“It’s easier if they’re at home…they do like the idea that they don’t have to go out and they’ll come to 
them.” (3) 
 
“I start talking to them about every medication. And I tell them ‘I’m here basically to make sure everything 
is OK.’” (Pharmacist) 
 
“Sometimes patients don’t know what their medications are for. They just say,’We just take it because the 
doctor wants us to take it.’ And so it’s my role to explain to them. I tell them, ‘You have the right to know. 
You need to know, because noone is going to look after you but yourself.’” (Pharmacist) 
The pharmacist’s 
recommendations are 
recorded in the 
electronic patient 
notes. 
“[the pharmacist] writes her recommendations directly into our software system and then the GP can 
access those.” (6) 
 
“[the pharmacist] does it by notes and then it comes up in a consultation and it's marked as her name so 
the doctors know that's her [comment].” (3) 
If appropriate, the 
pharmacist and GP 
have a conference 
about the patient, it 
may be short and 
informal or a formal 
case conference. 
”Well, I guess it is done sometimes where the pharmacist will go into the GP’s room and have a 
consultation with the GP and the patient… the actual recommendations and prescriptions afterwards is 
between the pharmacist and the GP.” (6) 
 
“[the pharmacist] goes out and visits them, she comes back here and speaks to the referring GP.” (2) 
 
“The pharmacist comes to see us after they’ve done the review… I found that quite useful, because a lot 
of—we have such a large patient base that you can’t carry it all in your head, every patient.” (9) 
A follow-up 
appointment is made 
with the GP. 
“… as long as the GP's available what we try to do is get them, if they're coming up here for an 
appointment, they see the pharmacist first and then we try and get them to see the GP after, to go 
through the recommendations straightaway so they're not going away and getting forgotten, or they just 












Table 3: Current roles—perceived value of the pharmacist’s provision of HMRs 
Value Quote(s) 
Assistance with patient 
understanding of 
medications 
“Because we do have more elderly patients, we’ve utilised our clinical pharmacist quite heavily 
here. Because there’s just confusion as to what do I take? When do I take it? What’s the dose? 
Obviously, contra-indications between different medications, and what not. That’s where we rely 
very heavily on [the pharmacist] to help our patients to sort it out.“ (2) 
Patient education and 
counselling 
“Warfarin management and things like that … educating patients on medicines and how they 
should be taking them and the importance of monitoring and things like that… in terms of 
adherence or compliance, it's more just reiterating the facts and you know, reinforcing why the 
patient is on the medication and what the importance of taking that medication is.” (6) 
Improved health outcomes 
for patients through 
medication changes  
“… sometimes the clinical interventions that I do are so simple, but it makes just a big difference 
in people’s life.” (Pharmacist) 
 
Communication with the GP  “But the feedback from the therapeutics is terrific. That’s really useful.” (9) 
 
“of the ones [recommendations] I’ve read she’s made good comments.” (GPB) 
Periodic re-evaluation of 
patients’ medications 
“Since this HMR review’s come, it’s been helpful. It’s like a sort of second opinion about 
medication and review. As you know, people are on medication for years, and it often never gets 
changed.” (9) 
Pharmacist’s knowledge of 
medications  
“…interactions of medications…if they’re on multiple medications and they’re seeing different 
GPs. Because they still feel that they can see one GP for one condition, one for another one and 
they don’t share that information.” (7) 
 
Table 4: Current roles—perceived acceptance of HMR process by patients 
View Quote(s) 
Not all patients agree 
to have one 
“Some don’t want anything to do with it, which is fine because it’s their choice, right? It’s just a free 
service offered to them.” (4) 
Some patients are 
resistant to change 
“But some … just resent it because they hear things that they don’t want to hear. They’re so used to 
taking the same thing and the same amount for so long that any change—it may be exactly the same 





“Sometimes other people are a bit funny because when you go and do home visits at home they think 
you’re there to check on them because you don’t think they are doing the right thing… ‘I am just 
physically here to make sure you know what your medications are for and you’re getting the best 
therapy.’ And so that changes totally the attitude of them.” (Pharmacist) 
Some patients 
embrace the process 
“I think, the feedback that we’ve been having from the patients, it’s that they now feel more confident 
in their medications… [the pharmacist’s] simplifying it for them. She’s making them healthier by 
making sure that the dosages are right, and just making it much less complex for them.” (2) 
 
Table 5: Current roles—pharmacist providing information to clinic staff 
Role Quote(s) 
New drugs “I think that pharmacists are underestimated personally. They’ve got a knowledge base on medications, 
which is incredibly important and also utilising medications in the right way. We’re pushed by drug reps to 
prescribe medications which aren’t necessarily any better than another one.” (GPA) 
 
“They come and ask me about medications all the time, the new medications. And I sit down and explain to 




“Most of the time it’s verbal, but sometimes when the doctors tell me they need more information, I go and 
do research and give them printout information.” (Pharmacist) 
Feedback “We are quite pleased with the information that we've been receiving from the clinical pharmacist, but also 
I guess the close interaction that we have in discussions with her around different patient management.” 
(6) 
 
“Well, certainly making us aware of some of the things like PPIs and Metformin and the impacts of [for 
example] B12 absorption and those sorts of things, just guiding some of the pathology investigations, I guess 















“It would be good if the pharmacist could actually look at the data and see is the patient too demanding, as in 
asking for too many scripts. Are they utilising it, is there a way of checking they are actually taking it? I think 
there would be a way of doing that… Are they taking the right medication, the right strength? Do we need to 
give them one medication; can we substitute with another one? Are they on multiple medications that are like 
a cocktail? Is there any way that we can reduce side effects? There are lots of core root methods that a 
pharmacist could do that, and you could do that by doing audits.” (7) 
 
“So I would like to have a pharmacist up there all the time, expand their role… one of the important roles could 
be data collection on what we're prescribing. Also finding out what the end result of it was… Find out what the 
result of giving the antibiotics is, in terms of side effects.  You could be looking at patients that didn't get 
antibiotics for upper respiratory and those who did… useful to have a pharmacist who looked at our pattern of 





“The other thing the pharmacist can do is also to update the record of the patient, optimising the medication… 
So if the pharmacist does optimising of that, that’s going to be an excellent idea for them to clean up the 
record and make it up to date with the instructions and what the current medications are.” (1) 
Further access to 
knowledge 
“We could certainly have some periodic open forums in the practice if it’s big enough, and invite local people 
along. Have the pharmacist there. I’m talking about the common things like diabetes and hypertension, heart 
failure, that sort of thing.” (8) 
Dispensing “Ideally, I suppose, in a super clinic, you want a dispensary. It’s really important. As I said, for the doctors, too, 
to have that feedback … When you’ve got one there, it’s like having an x-ray, a pathology unit, you’re 
constantly talking to them, and it improves the quality of care that you can dispense.” (GPC) 
Prescribing Hesitance about: 
“We prefer that they make an appointment [with the GP], then they get seen. To make sure they're on track… I 
mean we all know that there's so many repeats for a reason.” (3) 
 
“I mean the big problem we have here is patients wanting prescriptions and they don’t want to be seen, which 
you can’t do if you haven’t seen them in six months. In the past they may have done that. You can’t do that if 
they’re on blood pressure medication. You need to monitor their blood pressure, monitor their renal function, 
that kind of thing and that’s a slow process for patients to realise.” (7) 
 
“Actually changing medications and prescribing and things like that I don't know if that would be appropriate 
because the GP may be making decisions based on other clinical problems that the pharmacist isn't aware of.  
You know the GP might know the patient for 10 years and know all their history and what they've been on 
before and what they've been in hospital for… whereas the pharmacist doesn't have that scope to make those 
ultimate decisions.” (6) 
 
Support for: 
“If you had a pharmacist prescribe it, yes they could do that. You just see the GP once a year for review, or the 
nurse who can then liaise with the GP, and you’ve got the pharmacist next door who is quite happy to adjust 
medications up, down, perfect. I’m happy. I’ve done that. I’ve done that with pharmacists.” (7) 
 
“It would probably take a bit off the pressure of the doctors writing out scripts.” (5) 
 
“I think, absolutely, look, pharmacists, nurse practitioners, any number of people, and then we could actually 
go back to practicing some medicine, instead of spending probably 25–30 per cent of our time in routine 
procedures that aren’t really that medical.” (9) 
 
“Time management, ease-ability of seeing somebody, familiarity, same patient. The patient also… it’s them 
taking responsibility and realising if they come to the doctors it’s so efficient and they come back. Seeing 
results. Having the time. I mean that pharmacist does have the 10 minutes just to do a blood pressure whereas 
the doctor’s going to have to do whatever else they have to do. The results, they just talk for themselves, don’t 










Table 7: Constraints on potential future roles for the pharmacist 
Constraint Quote(s) 
Time availability “On my wish list would probably be for [the pharmacist] to be able—she is physically able to be here 
more frequently.” (2) 
 
“So I would like to have a pharmacist up there all the time.” (8) 
 
“You’d just simply have a time where the pharmacist is here. Not just one session a week, or 
something. [the pharmacist would] be here maybe twice a week.” (9) 
Funding 
availability 
“I guess we haven't really thought of these other things because they're not available because—I mean 
Medicare fund Home Medicines Reviews for patients with five or more medications.  So that's what 
we're going to use it for and that's basically the end of the story... at the end of the day I guess you 
can't bill for more than doing Home Medicines Review, which is what they're [pharmacists] going to 
do.” (6) 
Lack of funding 
for follow-up 
“… for me to do five or six follow-ups … I don’t get paid for them. There should be some sort of funding 
for follow ups for medication reviews.” (Pharmacist) 
 
“I think it would be lovely if they [the pharmacist] could come back periodically… after a two-month 
period and go, ‘So how did you get on?  Did you do any of this.’ Because at the moment there isn’t 
actually a scope to do that… It’s like, okay they’ve done this, but why have they not done this? Have 
they changed this? Why haven’t they changed this? Has it been beneficial? Has it not? So you’re 
probably even going to be able to do a pilot program to see: Is this working? Is it not working?” (7) 
 
